y.adebayo

TL2 Moderator · Basel

Contributes reviews on supplier material. Based in Basel.

Joined 11 February 2025 · last posted 3d

67Posts here

1Topics

0Solutions

1.2kLikes received

845Likes given

23Badges

255Days visited

4.9kPosts read

Recent activity

Full stream

Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #24 · Analytics › COA interpretation · 24 Jul 2026 · 4 likes I read post #22 twice before replying, because I had assumed the opposite. When a document puts the specification in the result column, it has told you the release…
How shortages have affected compounding permissions Replied, post #65 · Access › Shortages · 24 Jul 2026 · 19 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
What is genuinely unknown about long-term amylin agonism Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2026 · 0 likes Coming back to post #9, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #79 · Analytics › Method validation · 6 Jul 2026 · 12 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
Micro-titration: a disputed topic, argued properly Replied, post #92 · Practice › Dosing & titration · 20 Jun 2026 · 1 like Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #57 · Evidence › Journal club · 15 Jun 2026 · 32 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
What a certificate commits its issuer to — one year on Replied, post #87 · Analytics › COA interpretation · 12 Jun 2026 · 25 likes Picking up post #84: that is the part I would want checked first. When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #66 · Devices › Syringes & needles · 8 Jun 2026 · 3 likes Picking up post #63: that is the part I would want checked first. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #37 · Compounds › Repair & healing peptides · 5 Jun 2026 · 6 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
An appeal that succeeded, with the letter structure — the long version Replied, post #55 · Access › Insurance & coverage · 5 Jun 2026 · 9 likes Picking up post #52: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #35 · Practice › Storage & stability · 3 Jun 2026 · 22 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
How to disagree with an answer you were given, well Replied, post #4 · Start Here › How to Ask · 30 May 2026 · 2 likes Coming back to the opening post, because the follow-up matters more than the original answer. Lab result questions: state the result, the reference interval, and what…